<DOC>
	<DOCNO>NCT01070732</DOCNO>
	<brief_summary>The present study aim unravel clinical efficacy intravenously administer paracetamol antipyretic analgesic medication various medical condition .</brief_summary>
	<brief_title>Paracetamol Antipyretic Analgesic Medication</brief_title>
	<detailed_description>Although modern therapeutic target prolongation survival , despite underlying illness , also aim improvement quality life . Two major symptom affect considerably quality life , fever pain . Both symptoms common denominator vast number clinical situation good prognosis . Among situation like infectious disease , hematologic malignancy , solid tumor malignancy , connective tissue disorder factor connect surgical operation predominate . Post-operative pain extent long imposes severely post-operative course patient . A variety compound developed management fever pain , successful non-steroidal anti-inflammatory drug . They exist variety form various type administration . Those administer parenterally consider efficacious administer orally term rate achieve clinical effect . Furthermore , several condition necessitate parenteral administration . Paracetamol well-known antipyretic analgesic compound available many year oral administration since intravenous infusion hamper water insolubility . Its pro-drug , namely , pro-paracetamol , applied intravenous infusion amount 2g equally potent 1 g paracetamol . Pro-paracetamol give success analgesic medication woman undergo laparoscopic operation , antipyretic patient hematologic malignancy , antipyretic child bear infectious disease antipyretic critically ill patient . Ready-made paracetamol intravenous infusion market European country . It test four clinical trial . In first trial give post-operative analgesia dose 1g x 4 80 patient undergoing laparoscopic cholecystectomy . Clinical efficacy comparable parecoxib valdecoxib . In three study , give post-operative analgesia spinal body ectomy resection third mole provide conflict result . However , three latter study , number patient give paracetamol limited . In Greece , paracetamol intravenous infusion vial 1g/6.7ml manufacture company Uni-Pharma ( ΑPOTEL® ) . Based : ) limit number patient enrolled study mention earlier , b ) application form laparoscopic cholecystectomy spinal body ectomy , present study aim unravel clinical efficacy formula 1g intravenous paracetamol antipyretic analgesic medication various medical condition .</detailed_description>
	<mesh_term>Antipyretics</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Age great equal 18 year Written inform consent patient Medical condition necessitate administration antipyretic analgesic medication Αge low 18 year Lack inform consent History liver cirrhosis Blood creatinine great 3mg/dl Blood AST great 3 time upper normal level accord lab participate hospital History hypersensitivity nonsteroidal antinflammatory drug History abuse analgesic Pregnancy lactation Fulminant hemorrhage upper low digestive tract Thrombocytopenia define less 50000 platelets/μl</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Fever</keyword>
	<keyword>Infectious disease</keyword>
	<keyword>Neoplasia</keyword>
	<keyword>Pain</keyword>
	<keyword>cholecystectomy</keyword>
	<keyword>Colectomy</keyword>
</DOC>